The South African Health Products Regulatory Authority has announced it will facilitate a controlled, compassionate access programme for the use of Ivermectin. The anti-parasitic drug has gained popularity over recent weeks for its supposed benefits to treat COVID-19. SAHPRA once again stressed there was not enough scientific evidence to enable a regulator to make a decision on the drug’s use.

Published on

By Smile Staff Reporter


Add Smile FM on Google

Smile Staff Reporter
Smile Staff Reporter

Latest articles

Previous article
This year’s State of the Nation address will be a virtual, hybrid sitting, with only 50 people in the National Assembly chamber. This means less pomp and ceremony. The cost-saving will be used to modernise Parliament’s technological capabilities. It will take place on 11 Feb at 7 pm.
Next article
National Treasury’s Director-General Dondo Mogajane has maintained it has the funds to secure vaccines and that finance won’t be an issue for South Africans to receive doses. The cost of vaccinating about 40 million South Africans is estimated between 20 and 24 billion rand.

Joburg Ballet’s critically acclaimed Celestial Bodies heads to Cape Town this November

Smile Staff Reporter -
 Following its world premiere at Joburg Theatre in October 2025 and sold-out performances at the UJ Arts Centre in April 2026, Joburg Ballet’s critically...

Over a million citizens get Smart IDs with Home Affairs digital platform

Smile Staff Reporter -
  In just over seven months, more than one million South Africans have used the Department of Home Affairs’ digital measures to obtain Smart ID...

2026 Local Government Elections: What to expect on voting day

Smile Staff Reporter -
  South Africans heading to the polls on 4 November are encouraged to make sure they know where to vote, what identification they need and...